Anticoagulants are the cornerstone for prevention and treatment of thrombosis but are not
completely effective, and concerns about the risk of bleeding continue to limit their uptake …

Human tumors often trigger a hypercoagulable state that promotes hemostatic
complications, including venous thromboembolism. The recent application of systems …

The rising incidence and persistent thrombosis in multiple cancers including those that are
immunosuppressive highlight the need for understanding the tumor coagulome system and …

Background There are no data on the effect of low‐dose anticoagulation as secondary
prophylaxis for venous thromboembolism (VTE) in cancer patients. We assessed the efficacy …

Venous thrombosis is a frequent complication in cancer and is associated with high
morbidity and mortality. Hepatocellular carcinoma (HCC) is the most common primary liver …

Simple Summary The aim of this study was to investigate the relative contribution of PDGFB
derived specifically from platelets to the remodeling of the extracellular matrix (ECM) in …

Background Study aims were to analyze prospectively collected data from patients with
cancer-associated venous thromboembolism (VTE) to determine the impact of VTE …

Over the past four decades, percutaneous coronary intervention (PCI) safety and efficacy
have significantly improved, particularly with the advent of the drug-eluting stent (DES). First …

Opinion statement Prophylaxis and treatment of thrombosis in leukemic patients still
represent a major challenge with several clinical questions yet to be solved. Indeed, the …

Heparin and its derivatives are saving thousands of human lives annually, by successfully
preventing and treating thromboembolic events. Although the mode of action during …